Christopher Bowden
2019
Compensation breakdown
| Non-Equity Incentive Plan | $198,668 |
|---|---|
| Option Awards | $1,609,989 |
| Salary | $490,539 |
| Stock Awards | $915,590 |
| Other | $12,422 |
| Total | $3,227,208 |
Bowden received $1.6M in option awards, accounting for 50% of the total pay in 2019.
Bowden also received $198.7K in non-equity incentive plan, $490.5K in salary, $915.6K in stock awards and $12.4K in other compensation.
Rankings
In 2019, Christopher Bowden's compensation ranked 3,781st out of 13,971 executives tracked by ExecPay. In other words, Bowden earned more than 72.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,781 out of 13,971 | 73rd |
Division Manufacturing | 1,369 out of 5,692 | 76th |
Major group Chemicals And Allied Products | 478 out of 2,189 | 78th |
Industry group Drugs | 402 out of 1,875 | 79th |
Industry Pharmaceutical Preparations | 303 out of 1,387 | 78th |
Pay ratio
| Christopher Bowden's Pay | $3,227,208 |
|---|---|
| Median Employee's Pay | $267,104 |
| Pay Ratio | 12to 1 |
In 2019, the annual total compensation of Christopher Bowden was $3,227,208.
The annual total compensation of the median employee at Agios Pharmaceuticals was $267,104.
The ratio of Christopher Bowden's pay to the pay of median employee was therefore 12 to one.
Bowden's colleagues
We found five more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2019.
2019
Jacqualyn Fouse
Agios Pharmaceuticals
Chief Executive Officer
2019
Andrew Hirsch
Agios Pharmaceuticals
Chief Financial Officer
2019
Scott Biller
Agios Pharmaceuticals
Chief Scientific Officer
2019
Jonathan Biller
Agios Pharmaceuticals
Chief Legal Officer
2019
David Schenkein
Agios Pharmaceuticals
Chief Executive Officer
News
April 28, 2022
April 8, 2021
April 16, 2020
April 18, 2019